Filing Details
- Accession Number:
- 0000886163-13-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-01 15:27:18
- Reporting Period:
- 2013-06-28
- Filing Date:
- 2013-07-01
- Accepted Time:
- 2013-07-01 15:27:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237556 | W Matthew Foehr | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | Evp And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-28 | 1,059 | $17.36 | 44,929 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares Acquired under Ligand's employee stock purchase plan.
Billionaire Hedge Funds
